http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2010/09/16/bloomberg1376-L8UPKN0YHQ0X01-4IPERAC3V1DVPVC55IVQE41S5G.DTL Sept. 16 (Bloomberg) -- Arena Pharmaceuticals Inc. failed to win a U.S. panel's backing to sell lorcaserin, an experimental diet pill that would be the company's first drug. The San Diego-based company's medicine doesn't work well enough to justify potential risks when used long-term in overweight and obese patients, outside advisers to the Food and Drug Administration said in
【在 b***y 的大作中提到】 : http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2010/09/16/bloomberg1376-L8UPKN0YHQ0X01-4IPERAC3V1DVPVC55IVQE41S5G.DTL : Sept. 16 (Bloomberg) -- Arena Pharmaceuticals Inc. failed to win a U.S. : panel's backing to sell lorcaserin, an experimental diet pill that would be : the company's first drug. : The San Diego-based company's medicine doesn't work well enough to justify : potential risks when used long-term in overweight and obese patients, : outside advisers to the Food and Drug Administration said in